Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure.

@article{Palladini2012BestUO,
  title={Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure.},
  author={Giovanni Palladini and Andrea Foli and Paolo Milani and Paola Russo and Riccardo Albertini and Francesca Lavatelli and Laura Obici and Stefano Perlini and Remigio Moratti and Giampaolo Merlini},
  journal={American journal of hematology},
  year={2012},
  volume={87 5},
  pages={
          465-71
        }
}
In AL amyloidosis prognosis depends on the severity of heart dysfunction which is best assessed by natriuretic peptides (BNP and NT-proBNP). However, their clearance relies on glomerular filtration rate (GFR) and their concentration increases with renal failure. We evaluated the diagnostic and prognostic performance of NT-proBNP and BNP in 248 patients with AL amyloidosis with different degrees of renal failure. Patients were grouped according to GFR. Group 1 comprised 109 patients with GFR ≥60… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 30 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Similar Papers

Loading similar papers…